Masters Speciality Pharma

Established in 1984, Masters is principally engaged in the compliant sourcing of a broad range of established branded prescription drugs (or their generic equivalent) and pharmacy medicines. Albion funds successfully exited their investment in Masters in March 2017 

Masters Speciality Pharma Strengthens Capabilities in Brazil
Masters Speciality Pharma Enters Agreement with ApoPharma
Masters Speciality Pharma Signs Exclusivity Agreement with Speciality European Pharma
Andrew Elder
VCTs